My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 163

    1.

    A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice.

    Inagi R, Yamamoto Y, Nangaku M, Usuda N, Okamato H, Kurokawa K, van Ypersele de Strihou C, Yamamoto H, Miyata T.

    Diabetes. 2006 Feb;55(2):356-66.PMID: 16443768 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Reduction of albuminuria by angiotensin receptor blocker beyond blood pressure lowering: evaluation in megsin/receptor for advanced glycation end products/inducible nitric oxide synthase triple transgenic diabetic nephropathy mouse model.

    Ohtomo S, Ito M, Izuhara Y, Van Ypersele De Strihou C, Miyata T.

    Nephrology (Carlton). 2008 Dec;13(6):517-21. Epub 2008 Mar 17.PMID: 18363646 [PubMed - indexed for MEDLINE]Related articles

    3.

    Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.

    Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, Watanabe T, Yamagishi S, Sakurai S, Takasawa S, Okamoto H, Yamamoto H.

    J Clin Invest. 2001 Jul;108(2):261-8.PMID: 11457879 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Synergistic contributions of carbonyl stress and megsin in diabetic nephropathy.

    Inagi R, Nangaku M, Miyata T.

    Ann N Y Acad Sci. 2005 Jun;1043:605-8. Review.PMID: 16037283 [PubMed - indexed for MEDLINE]Related articles

    5.

    Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.

    Tanji N, Markowitz GS, Fu C, Kislinger T, Taguchi A, Pischetsrieder M, Stern D, Schmidt AM, D'Agati VD.

    J Am Soc Nephrol. 2000 Sep;11(9):1656-66.PMID: 10966490 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice.

    Fan Q, Liao J, Kobayashi M, Yamashita M, Gu L, Gohda T, Suzuki Y, Wang LN, Horikoshi S, Tomino Y.

    Nephrol Dial Transplant. 2004 Dec;19(12):3012-20.PMID: 15574998 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Receptor for advanced glycation end products is a promising target of diabetic nephropathy.

    Yamamoto Y, Doi T, Kato I, Shinohara H, Sakurai S, Yonekura H, Watanabe T, Myint KM, Harashima A, Takeuchi M, Takasawa S, Okamoto H, Hashimoto N, Asano M, Yamamoto H.

    Ann N Y Acad Sci. 2005 Jun;1043:562-6.PMID: 16037279 [PubMed - indexed for MEDLINE]Related articles

    8.

    RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.

    Myint KM, Yamamoto Y, Doi T, Kato I, Harashima A, Yonekura H, Watanabe T, Shinohara H, Takeuchi M, Tsuneyama K, Hashimoto N, Asano M, Takasawa S, Okamoto H, Yamamoto H.

    Diabetes. 2006 Sep;55(9):2510-22.PMID: 16936199 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Expression of megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases.

    Suzuki D, Miyata T, Nangaku M, Takano H, Saotome N, Toyoda M, Mori Y, Zhang SY, Inagi R, Endoh M, Kurokawa K, Sakai H.

    J Am Soc Nephrol. 1999 Dec;10(12):2606-13.PMID: 10589701 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Mesangial cell-predominant gene, megsin.

    Inagi R, Miyata T, Imasawa T, Nangaku M, Kurokawa K.

    Nephrol Dial Transplant. 2002;17 Suppl 9:32-3.PMID: 12386281 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease.

    He CJ, Zheng F, Stitt A, Striker L, Hattori M, Vlassara H.

    Kidney Int. 2000 Nov;58(5):1931-40.PMID: 11044213 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.

    Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R, Burns WC, Forbes JM, Calkin AC, Cooper ME, Jandeleit-Dahm KA.

    J Am Soc Nephrol. 2004 Aug;15(8):2125-38.PMID: 15284298 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation.

    Usui HK, Shikata K, Sasaki M, Okada S, Matsuda M, Shikata Y, Ogawa D, Kido Y, Nagase R, Yozai K, Ohga S, Tone A, Wada J, Takeya M, Horiuchi S, Kodama T, Makino H.

    Diabetes. 2007 Feb;56(2):363-72. Erratum in: Diabetes. 2007 Mar;56(3):897. Takeya, Masahiro [corrected to Takeya, Motohiro]. PMID: 17259380 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes.

    Kanetsuna Y, Hirano K, Nagata M, Gannon MA, Takahashi K, Harris RC, Breyer MD, Takahashi T.

    Am J Physiol Renal Physiol. 2006 Dec;291(6):F1315-22. Epub 2006 May 16.PMID: 16705146 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    RAGE in diabetic nephropathy.

    Yamamoto H, Watanabe T, Yamamoto Y, Yonekura H, Munesue S, Harashima A, Ooe K, Hossain S, Saito H, Murakami N.

    Curr Mol Med. 2007 Dec;7(8):752-7. Review.PMID: 18331233 [PubMed - indexed for MEDLINE]Related articles

    16.

    The AGE-RAGE system and diabetic nephropathy.

    Sakurai S, Yonekura H, Yamamoto Y, Watanabe T, Tanaka N, Li H, Rahman AK, Myint KM, Kim CH, Yamamoto H.

    J Am Soc Nephrol. 2003 Aug;14(8 Suppl 3):S259-63. Review.PMID: 12874443 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy.

    Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, Bucciarelli LG, Rong LL, Moser B, Markowitz GS, Stein G, Bierhaus A, Liliensiek B, Arnold B, Nawroth PP, Stern DM, D'Agati VD, Schmidt AM.

    Am J Pathol. 2003 Apr;162(4):1123-37.PMID: 12651605 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy.

    Suzuki D, Toyoda M, Yamamoto N, Miyauchi M, Katoh M, Kimura M, Maruyama M, Honma M, Umezono T, Yagame M.

    Intern Med. 2006;45(7):435-41. Epub 2006 May 1.PMID: 16679697 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury.

    Yonekura H, Yamamoto Y, Sakurai S, Watanabe T, Yamamoto H.

    J Pharmacol Sci. 2005 Mar;97(3):305-11. Epub 2005 Mar 5. Review.PMID: 15750291 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.

    Kaji Y, Usui T, Ishida S, Yamashiro K, Moore TC, Moore J, Yamamoto Y, Yamamoto H, Adamis AP.

    Invest Ophthalmol Vis Sci. 2007 Feb;48(2):858-65.PMID: 17251488 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity